oncnursingnews2h
FDA Approves Treosulfan With Fludarabine for alloHSCT Conditioning in AML and MDS
Treosulfan plus fludarabine was approved by the FDA for children and adults with AML or MDS before allogenic hematopoietic ...
Morningstar16d
Moleculin Highlights Development Progress of Annamycin, Phase 2 Data Outperforms Billion-Dollar Assets in AML, Phase 3 Data Readouts in 2025 & 2026
This early unblinding will yield 30 subjects with Annamycin (190mg/m2 and 230/m2 ... AnnAraC for the treatment of subjects with AML as both first line therapy and for subjects who are refractory ...